Xiaolin Zhu

5.8k total citations · 1 hit paper
140 papers, 3.0k citations indexed

About

Xiaolin Zhu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Xiaolin Zhu has authored 140 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Molecular Biology, 28 papers in Cancer Research and 21 papers in Oncology. Recurrent topics in Xiaolin Zhu's work include Epigenetics and DNA Methylation (12 papers), Plant Molecular Biology Research (11 papers) and Seed and Plant Biochemistry (10 papers). Xiaolin Zhu is often cited by papers focused on Epigenetics and DNA Methylation (12 papers), Plant Molecular Biology Research (11 papers) and Seed and Plant Biochemistry (10 papers). Xiaolin Zhu collaborates with scholars based in China, United States and Australia. Xiaolin Zhu's co-authors include Baoqiang Wang, Qinqin Gao, Slavé Petrovski, David B. Goldstein, Anna C. Need, Deng-feng Geng, Zhuzhi Wen, Yadong Wang, Jingfeng Wang and Yangxin Chen and has published in prestigious journals such as Journal of Clinical Oncology, Nature Neuroscience and Bioinformatics.

In The Last Decade

Xiaolin Zhu

133 papers receiving 2.9k citations

Hit Papers

A review of deep learning... 2023 2026 2024 2023 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaolin Zhu China 32 1.4k 553 369 301 252 140 3.0k
Rui Li China 36 1.7k 1.2× 611 1.1× 450 1.2× 274 0.9× 491 1.9× 176 3.8k
Yaron Guan‐Golan Israel 4 2.1k 1.5× 502 0.9× 465 1.3× 271 0.9× 259 1.0× 6 3.7k
Yaron Mazor Israel 7 2.1k 1.5× 488 0.9× 475 1.3× 272 0.9× 282 1.1× 7 3.7k
Sergey Kaplan Israel 2 1.9k 1.3× 451 0.8× 428 1.2× 255 0.8× 252 1.0× 3 3.4k
Yue Li China 31 1.4k 1.0× 538 1.0× 197 0.5× 275 0.9× 295 1.2× 199 3.3k
Asher Kohn Israel 4 2.5k 1.8× 612 1.1× 614 1.7× 298 1.0× 318 1.3× 5 4.3k
Gil Stelzer Israel 15 2.6k 1.9× 620 1.1× 575 1.6× 313 1.0× 318 1.3× 23 4.5k
Wei Zheng China 30 1.3k 0.9× 283 0.5× 403 1.1× 190 0.6× 303 1.2× 90 3.7k
Arnaud Droit Canada 36 2.1k 1.5× 468 0.8× 295 0.8× 304 1.0× 523 2.1× 183 3.8k

Countries citing papers authored by Xiaolin Zhu

Since Specialization
Citations

This map shows the geographic impact of Xiaolin Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaolin Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaolin Zhu more than expected).

Fields of papers citing papers by Xiaolin Zhu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaolin Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaolin Zhu. The network helps show where Xiaolin Zhu may publish in the future.

Co-authorship network of co-authors of Xiaolin Zhu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaolin Zhu. A scholar is included among the top collaborators of Xiaolin Zhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaolin Zhu. Xiaolin Zhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Guili, Yujie Liu, Jingjing Wang, et al.. (2024). IMT030122, A novel engineered EpCAM/CD3/4-1BB tri-specific antibody, enhances T-cell recruitment and demonstrates anti-tumor activity in mouse models of colorectal cancer. International Immunopharmacology. 137. 112424–112424. 5 indexed citations
2.
Liu, Dongming, Changfu Liu, Weihao Zhang, et al.. (2024). Sintilimab, bevacizumab biosimilar, and HAIC for unresectable hepatocellular carcinoma conversion therapy: a prospective, single-arm phase II trial. Neoplasma. 70(6). 811–818. 8 indexed citations
3.
Zhu, Xiaolin, Wenyu Liu, Baoqiang Wang, & Yang Ling. (2024). Molecular and physiological responses of two quinoa genotypes to drought stress. Frontiers in Genetics. 15. 1439046–1439046. 3 indexed citations
4.
Zhu, Xiaolin, Jijun Li, Lihua Zhang, et al.. (2023). Effect of Strain Rate on Nano-Scale Mechanical Behavior of A-Plane (112¯0) ZnO Single Crystal by Nanoindentation. Micromachines. 14(2). 404–404. 7 indexed citations
5.
Zhu, Xiaolin, Huiyan Jiang, & Zhaoshuo Diao. (2023). CGBO-Net: Cruciform structure guided and boundary-optimized lymphoma segmentation network. Computers in Biology and Medicine. 153. 106534–106534. 4 indexed citations
6.
Zeng, Rui, Fanghui Li, Jian Jiang, et al.. (2023). The Safety and Feasibility of Pulsed-Field Ablation in Atrioventricular Nodal Re-Entrant Tachycardia. JACC. Clinical electrophysiology. 10(1). 82–92. 6 indexed citations
7.
Zhu, Xiaolin, et al.. (2023). Non-targeted metabolomics analysis of metabolite changes in two quinoa genotypes under drought stress. BMC Plant Biology. 23(1). 503–503. 8 indexed citations
8.
Zhu, Xiaolin & Vadim S. Koshkin. (2023). Enfortumab vedotin and pembrolizumab as new first-line standard for metastatic urothelial cancer. Med. 5(2). 106–108. 3 indexed citations
9.
Zhou, Zhipeng, Yukun Song, Zhiyuan Song, Xiaolin Zhu, & Seunggu J. Han. (2023). 47TiP A real-world study of multiparametric prediction of the efficacy of immune checkpoint inhibitors in combination with chemotherapy for advanced non-small cell lung cancer. Immuno-Oncology Technology. 20. 100515–100515. 1 indexed citations
10.
12.
Zhu, Xiaolin, et al.. (2021). Genome-wide identification, characterization and expression analysis of the LIM transcription factor family in quinoa. Physiology and Molecular Biology of Plants. 27(4). 787–800. 13 indexed citations
13.
Yuan, Jian, Tongyang Gong, Dandan Fan, et al.. (2021). Loss of grand histone H3 lysine 27 trimethylation domains mediated transcriptional activation in esophageal squamous cell carcinoma. npj Genomic Medicine. 6(1). 65–65. 14 indexed citations
14.
Huang, Furong, Gang Ma, Xuantong Zhou, et al.. (2020). Depletion of LAMP3 enhances PKA-mediated VASP phosphorylation to suppress invasion and metastasis in esophageal squamous cell carcinoma. Cancer Letters. 479. 100–111. 19 indexed citations
15.
Heinzen, Erin L., Adam C. O’Neill, Xiaolin Zhu, et al.. (2018). De novo and inherited private variants in MAP1B in periventricular nodular heterotopia. PLoS Genetics. 14(5). e1007281–e1007281. 45 indexed citations
16.
Zhu, Xiaolin, Brett Copeland, Joshua Bridgers, et al.. (2017). A case-control collapsing analysis identifies epilepsy genes implicated in trio sequencing studies focused on de novo mutations. PLoS Genetics. 13(11). e1007104–e1007104. 17 indexed citations
17.
Sun, Lin, Manqing Cao, Hongyuan Zhou, et al.. (2017). Decreased expression of acetyl‐CoA synthase 2 promotes metastasis and predicts poor prognosis in hepatocellular carcinoma. Cancer Science. 108(7). 1338–1346. 41 indexed citations
18.
Heimer, Gali, Eran Eyal, Xiaolin Zhu, et al.. (2017). Mutations in AIFM1 cause an X-linked childhood cerebellar ataxia partially responsive to riboflavin. European Journal of Paediatric Neurology. 22(1). 93–101. 37 indexed citations
19.
Tao, Xiaoming, Jihu Li, Xiaolin Zhu, et al.. (2016). Association between socioeconomic status and metabolic control and diabetes complications: a cross-sectional nationwide study in Chinese adults with type 2 diabetes mellitus. Cardiovascular Diabetology. 15(1). 61–61. 62 indexed citations
20.
Liu, Yu, Yu Shi, Chun Zhang, et al.. (2009). Molecular variability of five Cucumber mosaic virus isolates from China. Acta Virologica. 53(2). 89–97. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026